Osteoarthritis
Conference Coverage
Nerve growth factor antibody cuts OA pain with low AEs
CHICAGO – First phase 3 results from an OA trial testing a nerve growth factor antibody, tanezumab.
News
Total knee replacement risk soars after arthroscopic surgery for meniscal tear
News
Brisk walking may decrease TKR risk in OA
CHICAGO – A dose-response in the amount of brisk walking was evident for TKR risk reduction.
Conference Coverage
Risk score validated for major NSAID adverse events
CHICAGO – Data from almost 24,000 patients on chronic NSAIDs produced a risk calculator for major NSAID-related adverse events.
Conference Coverage
Long-term follow-up results of ongoing trials highlighted at ACR 2018
Researchers will share long-term trial results in managing meniscal tears in osteoarthritis, treating glucocorticoid-induced osteoporosis, and...
News from the FDA/CDC
Anxiety and depression widespread among arthritis patients
Anxiety is far more common, but depression is more likely to be treated.
Conference Coverage
Opioid use in OA may mean more activity-limiting pain
LAS VEGAS – Persistent opioid use proved to be functionally limiting by the end of follow-up regardless of functional limitations at baseline.
From the Journals
Arthritis prevalent in older adults with any degree of depression
Older patients with depressive symptoms should be screened for arthritis-related pain.
Guidelines
Updates to EULAR hand OA management recommendations reflect current evidence
Latest News
Diclofenac’s cardiovascular risk confirmed in novel Nordic study
For the world’s most commonly used NSAID, the risk is real, according to 2 decades of Danish health data.
Daily News Podcast
Antibody cleared amyloid plaques, slowed cognitive decline
And claims that cannabis relieves noncancer pain go up in smoke.